Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002385842 | SCV002689113 | uncertain significance | Cardiovascular phenotype | 2019-09-23 | criteria provided, single submitter | clinical testing | The p.G443V variant (also known as c.1328G>T), located in coding exon 13 of the CACNB2 gene, results from a G to T substitution at nucleotide position 1328. The glycine at codon 443 is replaced by valine, an amino acid with dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Genomic Medicine Center of Excellence, |
RCV003992639 | SCV004809950 | uncertain significance | Brugada syndrome 4 | 2024-04-04 | criteria provided, single submitter | clinical testing |